Reproductive HIPAA Rule and the Purl Decision’s Implications

Rachel V. Rose
Rachel V. Rose | Rachel V. Rose – Attorney at Law, PLLC

Rachel V. Rose, JD, MBA (Houston, Texas) has a unique background, having worked in many different facets of healthcare, securities, cybersecurity, as well as international law and business throughout her career. For over a decade, her practice has focused on transactional, compliance, and litigation matters related to cybersecurity, health care, securities, and Dodd-Frank/False Claims Act whistleblower claims.

On-Demand: October 10, 2025

1 hour CLE

This program is only available to All-Access Pass Members.
Subscribe to Tax Rep Network CLE + myLawCLEs All-Access Pass...
Get this course, plus over 1,000+ live webinars.
Learn More

Program Summary

June 18, 2025 was a significant day for reproductive health care and HIPAA. The U.S. District Court for the Northern District of Texas - Amarillo Division (Carmen Purl, et al v. United States Department of Health and Human Services, et al., Case No. 2:24-cv-228-Z (N.D. Tex.)) an order vacating the HIPAA Privacy Rule to Support Reproductive Health Care Privacy, published on April 26, 2024, which amended the HIPAA Privacy Rule. The decision left intact amendments to the HIPAA rule regarding certain Notice of Privacy Practice provisions pertaining to substance use disorder regulations, which need to be adhered to by February 16, 2026. The purpose of this webinar is to delve into the case, the government’s subsequent actions and covered entities remaining responsibilities.

Key topics to be discussed:

  • Appreciate the impact of the Purl decision
  • Learn relevant aspects of HIPAA, including the law enforcement exception, which applies to all types of PHI
  • Understand what remains of the April 2024 Rule which require covered entities to implement by February 16, 2026

This course is co-sponsored with myLawCLE.

Closed-captioning available

Speakers

Speaker_Rachel-V.-RosRachel V. Rose | Rachel V. Rose – Attorney at Law, PLLC

Rachel V. Rose, JD, MBA (Houston, Texas) has a unique background, having worked in many different facets of healthcare, securities, cybersecurity, as well as international law and business throughout her career. For over a decade, her practice has focused on transactional, compliance, and litigation matters related to cybersecurity, health care, securities, and Dodd-Frank/False Claims Act whistleblower claims. She has conducted HIPAA Risk Analyses for a variety of domestic and international organizations and represented persons related to government enforcement inquiries and responses on cybersecurity and healthcare related matters. Ms. Rose worked on Capitol Hill when HIPAA passed in 1996 and worked at HHS in 2009 when the HITECH Act was being implemented.

In addition to being extensively published, a sought-after presenter, and quoted expert, Ms. Rose holds an MBA with minors in healthcare and entrepreneurship from Vanderbilt University, a law degree from Stetson University College of Law, and an Executive Certification in Leadership and Negotiation from Harvard Law School. She is also the co-editor of the American Health Lawyers Association’s Enterprise Risk Management Handbook for Healthcare Entities (2nd Edition), as well as a co-author of the ABA’s books The ABCs of ACOs and What Are International HIPAA Considerations?, as well as various chapters in legal and medical books alike.

She has been named consecutively to the Texas Bar College, the National Women Trial Lawyers Association’s Top 25, Houstonia Magazine’s Top Lawyers (healthcare), the National Trial Lawyers Association’s Top 100, SuperLawyers (healthcare), as well as 1st Healthcare Compliance’s 2019 and 2022 Top Presenter. Ms. Rose is also an Affiliated Member with the Baylor College of Medicine’s Center for Medical Ethics and Health Policy, where she teaches bioethics.

Agenda

I. Appreciate the impact of the Purl decision | 10:00am – 10:20am

II. Learn relevant aspects of HIPAA, including the law enforcement exception, which applies to all types of PHI | 10:20am – 10:40am

III. Understand what remains of the April 2024 Rule which require covered entities to implement by February 16, 2026 | 10:40am – 11:00am

Preview
More CLE Webinars
Upcoming CLE Webinars
Rules and Sanctions Related to Gen AI in Law
Rules and Sanctions Related to Gen AI in Law Fri, December 5, 2025
Live Webcast
Digital Evidence and Technology in MDL Litigation
Digital Evidence and Technology in MDL Litigation Wed, December 10, 2025
Live Webcast
A, B, C’s of Revocable and Irrevocable Trusts
A, B, C’s of Revocable and Irrevocable Trusts Thu, December 11, 2025
Live Webcast
Enforcement Priorities in a Trump FTC
Enforcement Priorities in a Trump FTC Wed, December 17, 2025
Live Webcast
Video Game Law for the Non-Game Lawyer
Video Game Law for the Non-Game Lawyer Wed, January 7, 2026
Live Webcast